Wikstrand CJ - Search Results

1

Kurpad SN, Zhao XG, Wikstrand CJ, Batra SK, McLendon RE, Bigner DD. Kurpad SN, et al. Among authors: wikstrand cj. Glia. 1995 Nov;15(3):244-56. doi: 10.1002/glia.440150306. Glia. 1995. PMID: 8586461 Review.

2

Monoclonal antibodies to malignant human gliomas.

Wikstrand CJ, Fredman P, Svennerholm L, Humphrey PA, Bigner SH, Bigner DD. Wikstrand CJ, et al. Mol Chem Neuropathol. 1992 Oct;17(2):137-46. doi: 10.1007/BF03159988. Mol Chem Neuropathol. 1992. PMID: 1384525 Review.

3

Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.

Longee DC, Wikstrand CJ, Månsson JE, He X, Fuller GN, Bigner SH, Fredman P, Svennerholm L, Bigner DD. Longee DC, et al. Among authors: wikstrand cj. Acta Neuropathol. 1991;82(1):45-54. doi: 10.1007/BF00310922. Acta Neuropathol. 1991. PMID: 1659106

4

Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivo.

Wikstrand CJ, He XM, Fuller GN, Bigner SH, Fredman P, Svennerholm L, Bigner DD. Wikstrand CJ, et al. J Neuropathol Exp Neurol. 1991 Nov;50(6):756-69. doi: 10.1097/00005072-199111000-00007. J Neuropathol Exp Neurol. 1991. PMID: 1748882

5

Relevance for neurobiology and neurooncology of antigens of malignant gliomas as defined by monoclonal antibodies.

Vrionis FD, Wikstrand CJ, Bigner DD. Vrionis FD, et al. Among authors: wikstrand cj. Ann N Y Acad Sci. 1988;540:64-77. doi: 10.1111/j.1749-6632.1988.tb27052.x. Ann N Y Acad Sci. 1988. PMID: 2462837 Review. No abstract available.

6

Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies.

Wikstrand CJ, Fredman P, Svennerholm L, Bigner DD. Wikstrand CJ, et al. Prog Brain Res. 1994;101:213-23. doi: 10.1016/s0079-6123(08)61951-2. Prog Brain Res. 1994. PMID: 7518092 Review.

7

Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro.

Wikstrand CJ, Fredman P, McLendon RR, Svennerholm L, Bigner DD. Wikstrand CJ, et al. Mol Chem Neuropathol. 1994 Feb-Apr;21(2-3):129-38. doi: 10.1007/BF02815347. Mol Chem Neuropathol. 1994. PMID: 7522005

8

Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.

Wikstrand CJ, Hale LP, Batra SK, Hill ML, Humphrey PA, Kurpad SN, McLendon RE, Moscatello D, Pegram CN, Reist CJ, et al. Wikstrand CJ, et al. Cancer Res. 1995 Jul 15;55(14):3140-8. Cancer Res. 1995. PMID: 7606735

9

Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.

Reist CJ, Archer GE, Kurpad SN, Wikstrand CJ, Vaidyanathan G, Willingham MC, Moscatello DK, Wong AJ, Bigner DD, Zalutsky MR. Reist CJ, et al. Among authors: wikstrand cj. Cancer Res. 1995 Oct 1;55(19):4375-82. Cancer Res. 1995. PMID: 7671250

10

Immunobiology of malignant astrocytomas.

Kurpad SN, Wikstrand CJ, Bigner DD. Kurpad SN, et al. Among authors: wikstrand cj. Semin Oncol. 1994 Apr;21(2):149-61. Semin Oncol. 1994. PMID: 8153661 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters